We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
ADLM 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Sensitive Blood Test Diagnoses Heart Attacks Faster

By LabMedica International staff writers
Posted on 24 Aug 2018
A high-sensitivity (hs) troponin T (cTnT) assay that has greater sensitivity and precision than the conventional fourth-generation cTnT assay currently in use in the USA has been recently approved.

The new high-sensitivity blood test for cardiac troponin, given in a hospital emergency room, was also found to be safe and effective. When patients present to emergency rooms with heart attack symptoms, doctors assess them in part by using a cardiac troponin test to measure a protein released into the blood when the heart is damaged.

Image: The Elecsys high-sensitivity cardiac troponin T (hs-cTnT) assay (Photo courtesy of Roche Diagnostics).
Image: The Elecsys high-sensitivity cardiac troponin T (hs-cTnT) assay (Photo courtesy of Roche Diagnostics).

Scientists at the University of Texas (UT) Southwestern Medical Center (Dallas, TX, USA) and their colleagues developed a procedure for assessing the results of the new test and compared it to existing practice using a conventional troponin test, which takes three hours to complete. Study participants were 536 patients admitted to an emergency room with heart attack symptoms, including chest pains and shortness of breath.

The team reported that in the cohort (mean age 55 years, 44% women), the final adjudicated diagnosis was myocardial infarction (MI) in 2.1%, unstable angina in 0.4%, and nonischemic myocardial injury in 17.0%. With the conventional assay, 80.4% of patients ruled out for MI at three hours. With the new hs-cTnT protocol, 83.8% ruled out by three hours, including 30.0% at baseline, 24.8% at one hour, and 28.9% at three hours. Compared with 19.6% of patients considered abnormal by the conventional assay, 16.2% of patients were abnormal under the new protocol.

Rebecca Vigen, MD, a cardiologist and lead author of the study, said, “We did not miss any heart attacks using this test in this population. The test also allowed us to determine faster that many patients who had symptoms of a heart attack were not having a heart attack than if we had relied on the traditional test. We anticipate that this procedure will allow many patients with chest pain to be given a 'yes' or 'no' diagnosis of whether they are having a heart attack faster.” The study was published on August 6, 2018, in the journal Circulation.

Related Links:
University of Texas (UT) Southwestern Medical Center


Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
Prefilled Tubes
Prefilled 5.0ml Tubes
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit

Latest Clinical Chem. News

Common HbA1c Assay May Miss Diabetes in People with Sickle Cell Trait
23 Aug 2018  |   Clinical Chem.

Blood Protein Panel Predicts Timing of ALS Symptom Onset
23 Aug 2018  |   Clinical Chem.

Siemens Adds CE-Marked Capillary Claims for 24 Assays on Atellica Analyzers
23 Aug 2018  |   Clinical Chem.



PURITAN MEDICAL